Literature DB >> 32865703

Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.

Behrooz Johari1,2,3, Hamed Rezaeejam4,5, Mohammad Moradi6, Zahraa Taghipour1, Zohreh Saltanatpour7, Yousef Mortazavi2,8, Leila Nasehi9,10.   

Abstract

Low sensitivity of cancer stem cells toward regular cancer therapy strategies is an important issue in the field of cancer remedy. The concept of cancer stem cell elimination has been a topic of interest in the field of molecular medicine for a long time. At the current study, it was aimed to elevate the sensitivity of cancer stem-like cells toward radiotherapy by treating with Oct4-Sox2 complex decoy oligodeoxynucleotides (ODNs). After treating HT29 and HT29-ShE cells with Oct4-Sox2 complex decoy ODNs, and analyzing the cellular uptake and localization of decoys, treated cells and control groups were subjected to irradiation by fractionated 6MV X-ray with a final dose of 2 Gy. Thereafter, the influence of radiotherapy on ODNs treated groups and control group was investigated on cell viability, cell cycle, apoptosis, colonosphere formation and scratch assay. Cellular uptake and localization assays demonstrated that decoy ODNs can efficiently be transfected to the cells and reside in subcellular compartment, where they pose their action on gene regulation. Post radiotherapy analysis indicated statistical significance in decoy ODNs treated cells by means of lower cell viability, cell cycle arrest in G2/M phase, increased cellular apoptosis, and reduced cell motility. Also, formed colonospheres were smaller in size and fewer in numbers. Considering the role of Oct4, and Sox2 transcription factors in signaling pathways of preserving stemness and inducing reverse EMT, application of decoy strategy could increase the sensitivity of cancer cells toward irradiation, which has a potential to eliminate the cancerous cells from tumors and support cancer treatment.

Entities:  

Keywords:  Cancer stem-like cell; Colon cancer; Decoy ODNs; Differentiation therapy; Radiotherapy

Mesh:

Substances:

Year:  2020        PMID: 32865703     DOI: 10.1007/s11033-020-05737-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  51 in total

Review 1.  Cancer stem cells.

Authors:  Craig T Jordan; Monica L Guzman; Mark Noble
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 2.  Current controversies in colon and rectal cancer.

Authors:  D M Vo; L A Julien; A G Thorson
Journal:  Minerva Chir       Date:  2010-12       Impact factor: 1.000

Review 3.  APC, signal transduction and genetic instability in colorectal cancer.

Authors:  R Fodde; R Smits; H Clevers
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 4.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

5.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 6.  Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review).

Authors:  Yuriko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2008-09       Impact factor: 4.101

Review 7.  Mesenchymal stem cells as potential therapeutic approaches in celiac disease.

Authors:  Ali Moheb-Alian; Flora Forouzesh; Mohammad Rostami-Nejad; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016-12

Review 8.  Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.

Authors:  Jeffrey Koury; Li Zhong; Jijun Hao
Journal:  Stem Cells Int       Date:  2017-03-05       Impact factor: 5.443

Review 9.  The implications of cancer stem cells for cancer therapy.

Authors:  Wenjing Jiang; Jianhua Peng; Yue Zhang; William C S Cho; Kunlin Jin
Journal:  Int J Mol Sci       Date:  2012-12-05       Impact factor: 5.923

Review 10.  Plant adaptation to drought stress.

Authors:  Supratim Basu; Venkategowda Ramegowda; Anuj Kumar; Andy Pereira
Journal:  F1000Res       Date:  2016-06-30
View more
  2 in total

Review 1.  Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer.

Authors:  Shreyasi Maity; Rishyani Mukherjee; Satarupa Banerjee
Journal:  Mol Biotechnol       Date:  2022-08-23       Impact factor: 2.860

2.  Evaluation of CRC-Metastatic Hepatic Lesion Chemoembolization with Irinotecan-Loaded Microspheres, According to the Site of Embolization.

Authors:  Marcin Szemitko; Elzbieta Golubinska-Szemitko; Marcin Warakomski; Aleksander Falkowski
Journal:  J Pers Med       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.